バイオシミラーの世界市場 2021年:メーカー別、地域別、種類・用途別

◆英語タイトル:Global Biosimilar Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21AR02250
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年4月
◆ページ数:106
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥382,800見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥574,200見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥765,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalInfoResearch社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

GlobalInfoResearch社の本調査レポートでは、バイオシミラーの世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオシミラーの種類別市場規模(ヒト成長ホルモン、モノクローナル抗体、インスリン、ペプチド、エリスロポエチン、その他)、用途別市場規模(腫瘍、慢性・自己免疫疾患、成長ホルモン欠乏症、感染症、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Allergan plc、BIOCAD、Biocon、BioXpress Therapeutics、Boehringer Ingelheim、Celltrion、Coherus BioSciences、Dr. Reddy’s Laboratories、Genor BioPharma、Intas Pharmaceuticals Limited、Novartis、Pfizer
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:ヒト成長ホルモン、モノクローナル抗体、インスリン、ペプチド、エリスロポエチン、その他
・用途別分析2016年-2026年:腫瘍、慢性・自己免疫疾患、成長ホルモン欠乏症、感染症、その他
・バイオシミラーの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・バイオシミラーのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・バイオシミラーのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・バイオシミラーの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・バイオシミラーの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Biosimilar size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Biosimilar market size is expected to grow at a CAGR of 23.9% for the next five years.

Market segmentation
Biosimilar market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others

Market segment by Application can be divided into
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others

The key market players for global Biosimilar market are listed below:
Allergan plc
BIOCAD
Biocon
BioXpress Therapeutics
Boehringer Ingelheim
Celltrion
Coherus BioSciences
Dr. Reddy’s Laboratories
Genor BioPharma
Intas Pharmaceuticals Limited
Novartis
Pfizer

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Biosimilar Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biosimilar Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Human Growth Hormones
1.2.3 Monoclonal Antibodies
1.2.4 Insulin
1.2.5 Peptides
1.2.6 Erythropoietin
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Biosimilar Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oncology
1.3.3 Chronic and Autoimmune Diseases
1.3.4 Growth Hormone Deficiency
1.3.5 Infectious Diseases
1.3.6 Others
1.4 Global Biosimilar Market Size & Forecast
1.4.1 Global Biosimilar Sales in Value (2016-2026))
1.4.2 Global Biosimilar Sales in Volume (2016-2026)
1.4.3 Global Biosimilar Price by Type (2016-2026) & (US$/Unit)
1.5 Global Biosimilar Production Capacity Analysis
1.5.1 Global Biosimilar Total Production Capacity (2016-2026)
1.5.2 Global Biosimilar Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Biosimilar Market Drivers
1.6.2 Biosimilar Market Restraints
1.6.3 Biosimilar Trends Analysis
2 Manufacturers Profiles
2.1 Allergan plc
2.1.1 Allergan plc Details
2.1.2 Allergan plc Major Business
2.1.3 Allergan plc Biosimilar Product and Services
2.1.4 Allergan plc Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 BIOCAD
2.2.1 BIOCAD Details
2.2.2 BIOCAD Major Business
2.2.3 BIOCAD Biosimilar Product and Services
2.2.4 BIOCAD Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Biocon
2.3.1 Biocon Details
2.3.2 Biocon Major Business
2.3.3 Biocon Biosimilar Product and Services
2.3.4 Biocon Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 BioXpress Therapeutics
2.4.1 BioXpress Therapeutics Details
2.4.2 BioXpress Therapeutics Major Business
2.4.3 BioXpress Therapeutics Biosimilar Product and Services
2.4.4 BioXpress Therapeutics Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Biosimilar Product and Services
2.5.4 Boehringer Ingelheim Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Celltrion
2.6.1 Celltrion Details
2.6.2 Celltrion Major Business
2.6.3 Celltrion Biosimilar Product and Services
2.6.4 Celltrion Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Coherus BioSciences
2.7.1 Coherus BioSciences Details
2.7.2 Coherus BioSciences Major Business
2.7.3 Coherus BioSciences Biosimilar Product and Services
2.7.4 Coherus BioSciences Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Dr. Reddy’s Laboratories
2.8.1 Dr. Reddy’s Laboratories Details
2.8.2 Dr. Reddy’s Laboratories Major Business
2.8.3 Dr. Reddy’s Laboratories Biosimilar Product and Services
2.8.4 Dr. Reddy’s Laboratories Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Genor BioPharma
2.9.1 Genor BioPharma Details
2.9.2 Genor BioPharma Major Business
2.9.3 Genor BioPharma Biosimilar Product and Services
2.9.4 Genor BioPharma Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Intas Pharmaceuticals Limited
2.10.1 Intas Pharmaceuticals Limited Details
2.10.2 Intas Pharmaceuticals Limited Major Business
2.10.3 Intas Pharmaceuticals Limited Biosimilar Product and Services
2.10.4 Intas Pharmaceuticals Limited Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business
2.11.3 Novartis Biosimilar Product and Services
2.11.4 Novartis Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Biosimilar Product and Services
2.12.4 Pfizer Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Biosimilar Sales by Manufacturer
3.1 Global Biosimilar Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Biosimilar Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Biosimilar
3.4 Market Concentration Rate
3.4.1 Top 3 Biosimilar Manufacturer Market Share
3.4.2 Top 6 Biosimilar Manufacturer Market Share
3.5 Global Biosimilar Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Biosimilar Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Biosimilar Market Size by Region
4.1.1 Global Biosimilar Sales in Volume by Region (2016-2026)
4.1.2 Global Biosimilar Revenue by Region (2016-2026)
4.2 North America Biosimilar Revenue (2016-2026)
4.3 Europe Biosimilar Revenue (2016-2026)
4.4 Asia-Pacific Biosimilar Revenue (2016-2026)
4.5 South America Biosimilar Revenue (2016-2026)
4.6 Middle East and Africa Biosimilar Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Biosimilar Sales in Volume by Type (2016-2026)
5.2 Global Biosimilar Revenue by Type (2016-2026)
5.3 Global Biosimilar Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Biosimilar Sales in Volume by Application (2016-2026)
6.2 Global Biosimilar Revenue by Application (2016-2026)
6.3 Global Biosimilar Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Biosimilar Sales by Type (2016-2026)
7.2 North America Biosimilar Sales by Application (2016-2026)
7.3 North America Biosimilar Market Size by Country
7.3.1 North America Biosimilar Sales in Volume by Country (2016-2026)
7.3.2 North America Biosimilar Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Biosimilar Sales by Type (2016-2026)
8.2 Europe Biosimilar Sales by Application (2016-2026)
8.3 Europe Biosimilar Market Size by Country
8.3.1 Europe Biosimilar Sales in Volume by Country (2016-2026)
8.3.2 Europe Biosimilar Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Biosimilar Sales by Type (2016-2026)
9.2 Asia-Pacific Biosimilar Sales by Application (2016-2026)
9.3 Asia-Pacific Biosimilar Market Size by Region
9.3.1 Asia-Pacific Biosimilar Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Biosimilar Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Biosimilar Sales by Type (2016-2026)
10.2 South America Biosimilar Sales by Application (2016-2026)
10.3 South America Biosimilar Market Size by Country
10.3.1 South America Biosimilar Sales in Volume by Country (2016-2026)
10.3.2 South America Biosimilar Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Biosimilar Sales by Type (2016-2026)
11.2 Middle East & Africa Biosimilar Sales by Application (2016-2026)
11.3 Middle East & Africa Biosimilar Market Size by Country
11.3.1 Middle East & Africa Biosimilar Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Biosimilar Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Biosimilar Typical Distributors
12.3 Biosimilar Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Biosimilar Revenue by Type, (USD Million), 2021-2026
Table 2. Global Biosimilar Revenue by Application, (USD Million), 2021-2026
Table 3. Allergan plc Basic Information, Manufacturing Base and Competitors
Table 4. Allergan plc Major Business
Table 5. Allergan plc Biosimilar Product and Services
Table 6. Allergan plc Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. BIOCAD Basic Information, Manufacturing Base and Competitors
Table 8. BIOCAD Major Business
Table 9. BIOCAD Biosimilar Product and Services
Table 10. BIOCAD Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Biocon Basic Information, Manufacturing Base and Competitors
Table 12. Biocon Major Business
Table 13. Biocon Biosimilar Product and Services
Table 14. Biocon Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. BioXpress Therapeutics Basic Information, Manufacturing Base and Competitors
Table 16. BioXpress Therapeutics Major Business
Table 17. BioXpress Therapeutics Biosimilar Product and Services
Table 18. BioXpress Therapeutics Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim Major Business
Table 21. Boehringer Ingelheim Biosimilar Product and Services
Table 22. Boehringer Ingelheim Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Celltrion Basic Information, Manufacturing Base and Competitors
Table 24. Celltrion Major Business
Table 25. Celltrion Biosimilar Product and Services
Table 26. Celltrion Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Coherus BioSciences Basic Information, Manufacturing Base and Competitors
Table 28. Coherus BioSciences Major Business
Table 29. Coherus BioSciences Biosimilar Product and Services
Table 30. Coherus BioSciences Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 32. Dr. Reddy’s Laboratories Major Business
Table 33. Dr. Reddy’s Laboratories Biosimilar Product and Services
Table 34. Dr. Reddy’s Laboratories Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Genor BioPharma Basic Information, Manufacturing Base and Competitors
Table 36. Genor BioPharma Major Business
Table 37. Genor BioPharma Biosimilar Product and Services
Table 38. Genor BioPharma Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Intas Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 40. Intas Pharmaceuticals Limited Major Business
Table 41. Intas Pharmaceuticals Limited Biosimilar Product and Services
Table 42. Intas Pharmaceuticals Limited Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Novartis Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Major Business
Table 45. Novartis Biosimilar Product and Services
Table 46. Novartis Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Pfizer Basic Information, Manufacturing Base and Competitors
Table 48. Pfizer Major Business
Table 49. Pfizer Biosimilar Product and Services
Table 50. Pfizer Biosimilar Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Biosimilar Sales by Manufacturer (2019-2021e) & (K Units)
Table 52. Global Biosimilar Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Biosimilar, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Biosimilar Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Biosimilar Production Site of Key Manufacturer
Table 56. Global Biosimilar Sales by Region (2016-2021e) & (K Units)
Table 57. Global Biosimilar Sales by Region (2021-2026) & (K Units)
Table 58. Global Biosimilar Revenue by Region (2016-2021e) & (USD Million)
Table 59. Global Biosimilar Revenue by Region (2021-2026) & (USD Million)
Table 60. Global Biosimilar Sales by Type (2016-2021e) & (K Units)
Table 61. Global Biosimilar Sales by Type (2021-2026) & (K Units)
Table 62. Global Biosimilar Revenue by Type (2016-2021e) & (USD Million)
Table 63. Global Biosimilar Revenue by Type (2021-2026) & (USD Million)
Table 64. Global Biosimilar Price by Type (2016-2021e) & (US$/Unit)
Table 65. Global Biosimilar Price by Type (2021-2026) & (US$/Unit)
Table 66. Global Biosimilar Sales by Application (2016-2021e) & (K Units)
Table 67. Global Biosimilar Sales by Application (2021-2026) & (K Units)
Table 68. Global Biosimilar Revenue by Application (2016-2021e) & (USD Million)
Table 69. Global Biosimilar Revenue by Application (2021-2026) & (USD Million)
Table 70. Global Biosimilar Price by Application (2016-2021e) & (US$/Unit)
Table 71. Global Biosimilar Price by Application (2021-2026) & (US$/Unit)
Table 72. North America Biosimilar Sales by Country (2016-2021e) & (K Units)
Table 73. North America Biosimilar Sales by Country (2021-2026) & (K Units)
Table 74. North America Biosimilar Revenue by Country (2016-2021e) & (USD Million)
Table 75. North America Biosimilar Revenue by Country (2021-2026) & (USD Million)
Table 76. North America Biosimilar Sales by Type (2016-2021e) & (K Units)
Table 77. North America Biosimilar Sales by Type (2021-2026) & (K Units)
Table 78. North America Biosimilar Sales by Application (2016-2021e) & (K Units)
Table 79. North America Biosimilar Sales by Application (2021-2026) & (K Units)
Table 80. Europe Biosimilar Sales by Country (2016-2021e) & (K Units)
Table 81. Europe Biosimilar Sales by Country (2021-2026) & (K Units)
Table 82. Europe Biosimilar Revenue by Country (2016-2021e) & (USD Million)
Table 83. Europe Biosimilar Revenue by Country (2021-2026) & (USD Million)
Table 84. Europe Biosimilar Sales by Type (2016-2021e) & (K Units)
Table 85. Europe Biosimilar Sales by Type (2021-2026) & (K Units)
Table 86. Europe Biosimilar Sales by Application (2016-2021e) & (K Units)
Table 87. Europe Biosimilar Sales by Application (2021-2026) & (K Units)
Table 88. Asia-Pacific Biosimilar Sales by Region (2016-2021e) & (K Units)
Table 89. Asia-Pacific Biosimilar Sales by Region (2021-2026) & (K Units)
Table 90. Asia-Pacific Biosimilar Revenue by Region (2016-2021e) & (USD Million)
Table 91. Asia-Pacific Biosimilar Revenue by Region (2021-2026) & (USD Million)
Table 92. Asia-Pacific Biosimilar Sales by Type (2016-2021e) & (K Units)
Table 93. Asia-Pacific Biosimilar Sales by Type (2021-2026) & (K Units)
Table 94. Asia-Pacific Biosimilar Sales by Application (2016-2021e) & (K Units)
Table 95. Asia-Pacific Biosimilar Sales by Application (2021-2026) & (K Units)
Table 96. South America Biosimilar Sales by Country (2016-2021e) & (K Units)
Table 97. South America Biosimilar Sales by Country (2021-2026) & (K Units)
Table 98. South America Biosimilar Revenue by Country (2016-2021e) & (USD Million)
Table 99. South America Biosimilar Revenue by Country (2021-2026) & (USD Million)
Table 100. South America Biosimilar Sales by Type (2016-2021e) & (K Units)
Table 101. South America Biosimilar Sales by Type (2021-2026) & (K Units)
Table 102. South America Biosimilar Sales by Application (2016-2021e) & (K Units)
Table 103. South America Biosimilar Sales by Application (2021-2026) & (K Units)
Table 104. Middle East & Africa Biosimilar Sales by Country (2016-2021e) & (K Units)
Table 105. Middle East & Africa Biosimilar Sales by Country (2021-2026) & (K Units)
Table 106. Middle East & Africa Biosimilar Revenue by Country (2016-2021e) & (USD Million)
Table 107. Middle East & Africa Biosimilar Revenue by Country (2021-2026) & (USD Million)
Table 108. Middle East & Africa Biosimilar Sales by Type (2016-2021e) & (K Units)
Table 109. Middle East & Africa Biosimilar Sales by Type (2021-2026) & (K Units)
Table 110. Middle East & Africa Biosimilar Sales by Application (2016-2021e) & (K Units)
Table 111. Middle East & Africa Biosimilar Sales by Application (2021-2026) & (K Units)
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Biosimilar Typical Distributors
Table 115. Biosimilar Typical Customers
List of Figures
Figure 1. Biosimilar Picture
Figure 2. Global Biosimilar Sales Market Share by Type in 2020
Figure 3. Human Growth Hormones
Figure 4. Monoclonal Antibodies
Figure 5. Insulin
Figure 6. Peptides
Figure 7. Erythropoietin
Figure 8. Others
Figure 9. Global Biosimilar Sales Market Share by Application in 2020
Figure 10. Oncology
Figure 11. Chronic and Autoimmune Diseases
Figure 12. Growth Hormone Deficiency
Figure 13. Infectious Diseases
Figure 14. Others
Figure 15. Global Biosimilar Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 16. Global Biosimilar Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. United States Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Canada Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Mexico Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Germany Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. France Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. United Kingdom Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Russia Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Italy Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. China Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Japan Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Korea Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. India Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Southeast Asia Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Australia Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Brazil Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Egypt Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Saudi Arabia Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. South Africa Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Turkey Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Global Biosimilar Sales (2016-2026) & (K Units)
Figure 37. Global Biosimilar Production Capacity (2016-2026) & (K Units)
Figure 38. Global Biosimilar Production Capacity by Geographic Region: 2020 VS 2021
Figure 39. Biosimilar Market Drivers
Figure 40. Biosimilar Market Restraints
Figure 41. Biosimilar Market Trends
Figure 42. Global Biosimilar Sales Market Share by Manufacturer in 2020
Figure 43. Global Biosimilar Revenue Market Share by Manufacturer in 2020
Figure 44. Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 45. Top 3 Biosimilar Manufacturer (Revenue) Market Share in 2020
Figure 46. Top 6 Biosimilar Manufacturer (Revenue) Market Share in 2020
Figure 47. Global Biosimilar Sales Market Share by Region (2016-2026)
Figure 48. Global Biosimilar Revenue Market Share by Region (2016-2026)
Figure 49. North America Biosimilar Revenue (2016-2026) & (USD Million)
Figure 50. Europe Biosimilar Revenue (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Biosimilar Revenue (2016-2026) & (USD Million)
Figure 52. South America Biosimilar Revenue (2016-2026) & (USD Million)
Figure 53. Middle East & Africa Biosimilar Revenue (2016-2026) & (USD Million)
Figure 54. Global Biosimilar Sales Market Share by Type (2016-2026)
Figure 55. Global Biosimilar Revenue Market Share by Type (2016-2026)
Figure 56. Global Biosimilar Price by Type (2016-2026) & (US$/Unit)
Figure 57. Global Biosimilar Sales Market Share by Application (2016-2026)
Figure 58. Global Biosimilar Revenue Market Share by Application (2016-2026)
Figure 59. Global Biosimilar Price by Application (2016-2026) & (US$/Unit)
Figure 60. North America Biosimilar Sales Market Share by Country (2016-2026)
Figure 61. North America Biosimilar Revenue Market Share by Country (2016-2026)
Figure 62. North America Biosimilar Sales Market Share by Type (2016-2026)
Figure 63. North America Biosimilar Sales Market Share by Application (2016-2026)
Figure 64. Europe Biosimilar Sales Market Share by Country (2016-2026)
Figure 65. Europe Biosimilar Revenue Market Share by Country (2016-2026)
Figure 66. Europe Biosimilar Sales Market Share by Type (2016-2026)
Figure 67. Europe Biosimilar Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Biosimilar Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Biosimilar Revenue Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Biosimilar Sales Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Biosimilar Sales Market Share by Application (2016-2026)
Figure 72. South America Biosimilar Sales Market Share by Country (2016-2026)
Figure 73. South America Biosimilar Revenue Market Share by Country (2016-2026)
Figure 74. South America Biosimilar Sales Market Share by Type (2016-2026)
Figure 75. South America Biosimilar Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Biosimilar Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Biosimilar Revenue Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Biosimilar Sales Market Share by Type (2016-2026)
Figure 79. Middle East & Africa Biosimilar Sales Market Share by Application (2016-2026)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


【掲載企業】

Allergan plc、BIOCAD、Biocon、BioXpress Therapeutics、Boehringer Ingelheim、Celltrion、Coherus BioSciences、Dr. Reddy’s Laboratories、Genor BioPharma、Intas Pharmaceuticals Limited、Novartis、Pfizer

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[バイオシミラーの世界市場 2021年:メーカー別、地域別、種類・用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆